Literature DB >> 24100385

Gut TFH and IgA: key players for regulation of bacterial communities and immune homeostasis.

Lucia M Kato1, Shimpei Kawamoto1, Mikako Maruya1, Sidonia Fagarasan1.   

Abstract

The main function of the immune system is to protect the host against pathogens. However, unlike the systemic immune system, the gut immune system does not eliminate, but instead nourishes complex bacterial communities and establishes advanced symbiotic relationships. Immunoglobulin A (IgA) is the most abundant antibody isotype in mammals, produced mainly in the gut. The primary function of IgA is to maintain homeostasis at mucosal surfaces, and studies in mice have demonstrated that IgA diversification has an essential role in the regulation of gut microbiota. Dynamic diversification and constant adaptation of IgA responses to local microbiota require expression of activation-induced cytidine deaminase by B cells and control from T follicular helper and Foxp3(+) T cells in germinal centers (GCs). We discuss the finely tuned regulatory mechanisms for IgA synthesis in GCs of Peyer's patches and emphasize the roles of CD4(+) T cells for IgA selection and the maintenance of appropriate gut microbial communities required for immune homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100385     DOI: 10.1038/icb.2013.54

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  42 in total

Review 1.  Eosinophils: important players in humoral immunity.

Authors:  C Berek
Journal:  Clin Exp Immunol       Date:  2015-09-28       Impact factor: 4.330

Review 2.  Role of secretory IgA in the mucosal sensing of commensal bacteria.

Authors:  Amandine Mathias; Bruno Pais; Laurent Favre; Jalil Benyacoub; Blaise Corthésy
Journal:  Gut Microbes       Date:  2014

3.  Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells.

Authors:  R De Bruyne; D Bogaert; N De Ruyck; B N Lambrecht; M Van Winckel; P Gevaert; M Dullaers
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

Review 4.  Immune and genetic gardening of the intestinal microbiome.

Authors:  Jonathan P Jacobs; Jonathan Braun
Journal:  FEBS Lett       Date:  2014-03-05       Impact factor: 4.124

5.  Decreased PD-1/PD-L1 Expression Is Associated with the Reduction in Mucosal Immunoglobulin A in Mice with Intestinal Ischemia Reperfusion.

Authors:  Xu-Yu Zhang; Zi-Meng Liu; Hu-Fei Zhang; Yun-Sheng Li; Shi-Hong Wen; Jian-Tong Shen; Ke-Xuan Liu
Journal:  Dig Dis Sci       Date:  2015-05-06       Impact factor: 3.199

Review 6.  N-3 polyunsaturated fatty acids modulate B cell activity in pre-clinical models: Implications for the immune response to infections.

Authors:  Jarrett Whelan; Kymberly M Gowdy; Saame Raza Shaikh
Journal:  Eur J Pharmacol       Date:  2015-05-27       Impact factor: 4.432

Review 7.  The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome.

Authors:  William E Ruff; Silvio M Vieira; Martin A Kriegel
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

Review 8.  Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism.

Authors:  Charlotte S Kaetzel
Journal:  Immunol Lett       Date:  2014-05-27       Impact factor: 3.685

9.  Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa.

Authors:  Geetha H Mylvaganam; Vijayakumar Velu; Jung-Joo Hong; Shanmugalakshmi Sadagopal; Suefen Kwa; Rahul Basu; Benton Lawson; Francois Villinger; Rama Rao Amara
Journal:  J Immunol       Date:  2014-09-22       Impact factor: 5.422

10.  PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.

Authors:  Jerome T McKay; Marcela A Haro; Christina A Daly; Rama D Yammani; Bing Pang; W Edward Swords; Karen M Haas
Journal:  J Immunol       Date:  2017-08-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.